Answers are grounded in this paper and cite their sources.
Immunohistochemistry (IHC) is a widely used technique for detecting proteins in tissue sections; however, its performance is significantly influenced by the quality of antibodies and detection strategies. Conventional IgG or IgM-based antibodies often come with high production costs, variability between batches, and limited penetration into tissues, which can compromise the uniformity and reproducibility of staining. Recombinant single-chain variable fragments (scFvs) offer an attractive alternative due to their smaller size, defined molecular composition, and renewable production capabilities. In this work, we focus on optimizing IHC by chemically biotinylating scFvs, allowing for direct coupling to streptavidin-based detection systems. This method enhances signal sensitivity while eliminating the need for secondary antibodies or additional labeling steps. Biotinylated scFvs can diffuse more easily into tissue sections, streamline the staining workflow, and reduce both assay time and cost. Overall, integrating biotinylated scFvs into IHC protocols presents a robust, scalable, and reproducible strategy that addresses key limitations of conventional antibody-based methods, thus supporting more consistent and efficient protein detection in histological analyses.This protocol allowed the optimization of conventional IHC conditions by using biotinylating scFv to achieve precise, time and cost-efficient antigen visualization.
No takes yet. Share an insight, caveat, or question.
Rodríguez-Nava et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: